Ngomhla wesi-5 kweyoMqungu, ngowama-2021, iShangke Biopharmaceutical (Shanghai) Co., Ltd. yanikwa iprojekthi yoGuqulelo lweMpumelelo yeShanghai High-tech "(S)-1-tert-butoxycarbonyl-3-hydroxypiperidine".
Njengeshishini lesizwe elinobuchwepheshe obuphezulu, iSuntech Biotech isoloko isebenzisa i-biotechnology ukukhokela uphuhliso lweshishini leekhemikhali kunye namayeza, kwaye izisa uhlaza kunye nempilo ebantwini njengomsebenzi wayo. Ukwandisa ishishini ngeendlela ezininzi, ukusebenzisana ngokukhutheleyo nezikolo kunye namashishini aziwayo ekhaya nakwamanye amazwe, rhoqo iphuhlisa amandla ayo ophuhliso, iphucule ulwakhiwo lwangaphakathi lweshishini, kwaye ibe ngcono kwaye yomelele.
Igama leprojekthi: (S)-1-tert-Butoxycarbonyl-3-hydroxypiperidine
Inombolo yento: 202010694
Inqanaba lento: B
Ingaba kukho impumelelo kwicandelo lobuchwepheshe obuphezulu elinamalungelo obunikazi obuzimeleyo: Ewe
Ukusetyenziswa: (S)-1-tert-butoxycarbonyl-3-hydroxypiperidine (CAS: 143900-44-1) liyeza elibalulekileyo le-chiral lokwenziwa kwee-API ze-ibrutinib. I-Ibrutinib liyeza elitsha lokulwa nomhlaza elijolise kwi-B-cell mognancies elavunywa phantsi kwemvume ekhawulezileyo yi-US Food and Drug Administration (FDA) ngoNovemba 13, 2013 kunyango lwe-lymphoma.
Inkcazo yotshintsho lwempumelelo yobuchwepheshe obuphezulu
Utshintsho lwempumelelo yezobuchwepheshe obuphezulu lubhekisa kwinkqubo apho amashishini enza imveliso kunye nomsebenzi wezobuchwepheshe obuphezulu. Urhulumente uxhasa amashishini ukuba aphumeze utshintsho lwempumelelo yesayensi nezobuchwepheshe ngophando oluzimeleyo nophuhliso, ukunika iilayisenisi, ukuthatha amasheya ngexabiso, nokusebenzisana namashishini, iiyunivesithi kunye namaziko ophando. Kwiiprojekthi zotshintsho lwempumelelo yezobuchwepheshe obuphezulu eziphononongiweyo kwaye zixelwe yishishini, ngokwendlela ezigqityiwe ngayo izalathisi zalo ezibanzi zoqoqosho kunye neempawu zamalungelo epropathi yengqondo yeprojekthi, inqanaba lokuvelisa izinto ezintsha, njl.njl., utyalo-mali lwayo lwe-R&D lunxulumene namalungelo epropathi yengqondo enxulumene neprojekthi, izatifikethi zepatent zokuyila, okanye ezo zingena kwinqanaba lovavanyo olubalulekileyo. Isatifiketi sokuhlonipha esinikwa ishishini emva kophononongo olungqongqo kunye nophando olunzulu lwemarike, njengezixhobo zobungqina besicelo sepatent yokuyila, isatifiketi sepatent yemodeli yokusetyenziswa, isatifiketi sokubhaliswa kwelungelo lokushicilela lesoftware, isatifiketi sokubhaliswa koyilo lwesekethe edibeneyo, njl.njl.
Iprofayile yekhampani
I-Shangke Biomedical (Shanghai) Co., Ltd. yasungulwa ngo-2008 kwaye ikwi-International Medical Park, kummandla osemazantsi eZhangjiang Hi-Tech Park, ePudong, eShanghai. Yinkampani ephethwe ngokupheleleyo yiZhejiang Shangke Biomedical Co., Ltd. I-Shangke Bio izimisele kuphando nophuhliso lwentsimi yamayeza aluhlaza asemgangathweni ophezulu, ikhokela uphuhliso lweshishini lamayeza amakhemikhali nge-biotechnology eluhlaza, kwaye ibonelela ngeemveliso ezintsha kunye neenkonzo ezisemgangathweni ophezulu kwishishini lamayeza. Lishishini lobuchwepheshe obuphezulu eShanghai kwaye likwalishishini lobuchwepheshe obuphezulu laseShanghai "elikhethekileyo, elicociweyo, elikhethekileyo nelitsha".
Ishishini eliphambili leSuntech liquka: uphuhliso kunye nokusetyenziswa kwee-enzymes zebhayoloji, uphuhliso kunye nokuveliswa kwezinto ezidityanisiweyo zamayeza, ii-API kunye neekhemikhali ezisebenzayo. Iimveliso eziphambili zenkampani ziimveliso ze-coenzyme, kuquka i-NMN, i-NAD, i-NADP, i-NADH, i-NADPH, ii-enzymes zebhayoloji, izinto ezikrwada zamayeza kunye nezinto ezidityanisiweyo. Abathengi kunye namaqabane enkampani akwihlabathi liphela, kwaye enze ubudlelwane obusondeleyo neenkampani ezininzi zamayeza eMntla Melika, eYurophu, eIndiya naseTshayina.
Ixesha lokuposa: Jan-15-2021